Sasaki M, Watanabe H, Jass J R, Ajioka Y, Kobayashi M, Matsuda K, Hatakeyama K
First Department of Pathology, Niigata University School of Medicine, Japan.
J Gastroenterol. 1997 Dec;32(6):758-64. doi: 10.1007/BF02936951.
There is controversy about the prognostic significance of occult lymph node metastases detected by immunohistochemistry with the anti-cytokeratin antibody CAM 5.2. The aim of this study was to characterize occult lymph node metastases in colorectal carcinomas that might be associated with a higher risk of recurrence. Three hundred fifty-eight lymph nodes from 10 recurrent and 9 nonrecurrent cases of colorectal carcinoma were examined. All these patients had been reported originally as having no lymph node metastases by routine hematoxylin and eosin staining. Three 10-micron sections or ten 3-micron sections (30-micron total thickness) from each lymph node were stained with CAM 5.2 and examined for the presence of occult lymph node metastases. Occult metastases were detected in 67 of 175 lymph nodes from the recurrent cases, and in 23 of 183 lymph nodes from the nonrecurrent cases. The frequency of positive nodes was significantly higher in the recurrent cases. The recurrent cases had metastases in nodes more distant from the main tumor than did the nonrecurrent cases. Detection of occult lymph node metastases with cytokeratin immunohistochemistry may make it possible to identify patients with a higher risk of recurrence after the removal of a primary colorectal tumor.
关于采用抗细胞角蛋白抗体CAM 5.2免疫组化检测隐匿性淋巴结转移的预后意义存在争议。本研究的目的是对结直肠癌中可能与较高复发风险相关的隐匿性淋巴结转移进行特征描述。对10例复发性和9例非复发性结直肠癌患者的358个淋巴结进行了检查。所有这些患者最初经常规苏木精和伊红染色报告无淋巴结转移。每个淋巴结切取3张10微米厚的切片或10张3微米厚的切片(总厚度30微米),用CAM 5.2染色,检查是否存在隐匿性淋巴结转移。在复发性病例的175个淋巴结中,有67个检测到隐匿性转移;在非复发性病例的183个淋巴结中,有23个检测到隐匿性转移。复发性病例中阳性淋巴结的频率显著更高。与非复发性病例相比,复发性病例的转移淋巴结距离主要肿瘤更远。采用细胞角蛋白免疫组化检测隐匿性淋巴结转移可能有助于识别原发性结直肠癌切除术后复发风险较高的患者。